U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 19 results

Status:
US Approved Rx (2015)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Uridine triacetate (formally PN401) is an acetylated prodrug of uridine. Following oral administration, uridine triacetate is deacetylated by nonspecific esterases present throughout the body, yielding uridine in the circulation. Uridine triacetate u...
Status:
US Approved Rx (2013)
First approved in 2004

Class (Stereo):
CHEMICAL (ABSOLUTE)



Azacitidine (Vidaza; Pharmion), an inhibitor of DNA methylation, was approved by the US FDA for the treatment of myelodysplastic syndromes in May 2004. It is the first drug to be approved by the FDA for treating this rare family of bone-marrow disord...
Status:
US Approved Rx (2018)
First approved in 1998

Class (Stereo):
CHEMICAL (ABSOLUTE)



Capecitabine is a fluoropyrimidine carbamate with antineoplastic activity. It is an orally administered systemic prodrug which is converted to 5-fluorouracil (5-FU). Both normal and tumor cells metabolize 5-FU to 5-fluoro-2’-deoxyuridine monophosphat...
Status:
US Approved Rx (2023)
First approved in 1977

Class (Stereo):
CHEMICAL (ACHIRAL)



Carmustine is a cancer medication that interferes with the growth and spread of cancer cells in the body. Carmustine is used to treat brain tumors, Hodgkin's disease, multiple myeloma, and non-Hodgkin's lymphoma. Although it is generally agreed that ...
Status:
US Approved Rx (1976)
First approved in 1976

Class (Stereo):
CHEMICAL (ACHIRAL)

Targets:


Lomustine is used in the treatment of certain neoplastic diseases. Although it is generally agreed that lomustine alkylates DNA and RNA, it is not cross resistant with other alkylators. As with other nitrosoureas, it may also inhibit several key enzy...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)

Targets:

Conditions:

8-Azaguanine is a purine analog which resembles guanine close enough to compete with it in the metabolism of living organisms. It has been widely studied and has shown to cause retardation of some malignant neoplasms when administered to tumors in an...
Status:
Other

Class (Stereo):
CHEMICAL (ACHIRAL)

Targets:

Status:
Other

Class (Stereo):
CHEMICAL (ABSOLUTE)

Targets:

Showing 1 - 10 of 19 results